-
2 weeks ago | 
healio.com | Michela Cimberle
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
3 weeks ago | 
healio.com | W. Clark |Michela Cimberle
April 24, 2025 3 min watch VIDEO: Will sustained drug delivery be the new treatment paradigm for retinal disease? Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Retina/Vitreous in Ophthalmology. Subscribe Added to email alerts You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published.
-
3 weeks ago | 
healio.com | Michela Cimberle
Key takeaways: One speaker argued that general ophthalmologists could improve early diagnosis of glaucoma. Another said glaucoma is a complex disease that necessitates specialist-level knowledge. SEVILLE, Spain — While glaucoma prevalence is growing, glaucoma specialists are in short supply, and accessibility to specialized centers is limited. Can this gap be filled by general ophthalmologists? This issue was debated at the Congress on Controversies in Ophthalmology.
-
3 weeks ago | 
healio.com | M. Francesca Cordeiro |Michela Cimberle
SEVILLE, Spain — In this Healio Video Perspective, M. Francesca Cordeiro, MD, PhD, summarizes three more hot topics in glaucoma discussed at the Congress on Controversies in Ophthalmology. The questions included: Should comprehensive ophthalmologists or glaucoma specialists manage glaucoma? Should glaucoma drops be preservative free from the start of treatment? Are minimally invasive bleb surgeries better than traditional trabeculectomy?
-
4 weeks ago | 
healio.com | M. Francesca Cordeiro |Michela Cimberle |Christine Klimanskis
SEVILLE, Spain — In this Healio Video Perspective, M. Francesca Cordeiro, MD, PhD, highlights three hot topics in glaucoma discussed at the Congress on Controversies in Ophthalmology. During COPHy’s glaucoma sessions, which Cordeiro co-chaired, several questions were addressed: Is phaco plus minimally invasive glaucoma surgery better than phaco alone? Is AI better than clinicians at making decisions? Is it possible to prevent glaucoma?
-
1 month ago | 
healio.com | Michela Cimberle
Key takeaways: One specialist proposed that new-generation anti-VEGFs show better efficacy. Another said there is a lack of high-level evidence in this area. SEVILLE, Spain — Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature. It is often difficult to treat, requires a higher than average number of injections and can often lead to retinal pigment epithelial (RPE) tears.
-
1 month ago | 
healio.com | Michela Cimberle |Christine Klimanskis |Nancy M. Holekamp |Rodrigo Gonzalez |Rodrigo González
Key takeaways: One presenter said at-home OCT has the potential to improve outcomes in neovascular AMD through personalized care. Another said there are still barriers to overcome with monitoring programs. SEVILLE, Spain — Home monitoring of neovascular age-related macular degeneration, an interesting concept with many potential benefits, has entered the retina space in the U.S. with the Scanly Home OCT monitoring program from Notal Vision.
-
1 month ago | 
healio.com | Michela Cimberle |Christine Klimanskis
Key takeaways:One specialist argued that, in the future, gene therapy technologies will be the favored option for wet AMD. Another emphasized that there are still challenges and limitations that need to be overcome. SEVILLE, Spain — Gene therapy is an area of intensive research and development in the retina space, with promising prospects and significant challenges. The benefits and pitfalls of gene therapy were discussed by two specialists at the Congress on Controversies in Ophthalmology.
-
1 month ago | 
healio.com | Michela Cimberle |Christine Klimanskis
Key takeaways:One presenter said there is sufficient evidence supporting atropine to slow myopia progression. Another said inconsistent study designs do not support atropine as the standard of care. SEVILLE, Spain — Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.
-
1 month ago | 
healio.com | Anat Loewenstein |Baruch D. Kuppermann |Michela Cimberle
SEVILLE, Spain — In this Healio Video Perspective, Anat Loewenstein, MD, MHA, and Baruch D. Kuppermann, MD, PhD, highlight topics discussed at the Congress on Controversies in Ophthalmology. “We’ve had a lot of interesting debates with great participation all around,” Kuppermann said. Basic research, emerging therapies, futuristic approaches and pragmatic management issues were addressed from different perspectives in the fields of retina, glaucoma, neuro-ophthalmology and uveitis.
